Psychotropic Medication in Intellectual and Developmental Disabilities: Patterns of Use and Recommendations for Monitoring Effects

[1] Deb S(2007)Psychotropic medication for behaviour problems in people with intellectual disability: a review of the current literature Curr Opin Psychiatry 20 461-466

[2] Unwin G(2014)Use of medication for challenging behavior in people with intellectual disability Br J Psychiatry 205 6-7

[3] Glover G(2010)Pharmacotherapy for aggressive behaviours in persons with intellectual disabilities: treatment or mistreatment? J Intellect Disabil Res 54 1-16

[4] Bernard S(2014)Drug treatments in people with intellectual disability and challenging behaviour: time to rethink? BMJ Clin Res 348 g4323-726

[5] Brandford D(2012)Medications for adolescents and young adults with autism spectrum disorders: a systematic review Pediatr 130 717-77

[6] Holland A(2014)Lessons learned from our elders: how to study polypharmacy in populations with intellectual and developmental disabilities Intellect Dev Disabil 52 60-513

[7] Strydom A(2015)Adverse Events in Very Young Children Prescribed Psychotropic Medications: Preliminary Findings from an Acute Clinical Sample Journal of Child and Adolescent Psychopharmacology 25 509-436

[8] Tsiouris JA(2018)Puberty and the human brain: insights into adolescent development Neurosci Biobehav Rev 92 417-557

[9] Tyrer P(2018)Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research Ther Adv Drug Saf 9 535-103

[10] Hassiotis A(2016)Prevalence and putative risk markers of challenging behavior in students with intellectual disabilities Res Dev Disabil 58 94-489

[1] Deb S(2007)Psychotropic medication for behaviour problems in people with intellectual disability: a review of the current literature Curr Opin Psychiatry 20 461-466

[2] Unwin G(2014)Use of medication for challenging behavior in people with intellectual disability Br J Psychiatry 205 6-7

[3] Glover G(2010)Pharmacotherapy for aggressive behaviours in persons with intellectual disabilities: treatment or mistreatment? J Intellect Disabil Res 54 1-16

[4] Bernard S(2014)Drug treatments in people with intellectual disability and challenging behaviour: time to rethink? BMJ Clin Res 348 g4323-726

[5] Brandford D(2012)Medications for adolescents and young adults with autism spectrum disorders: a systematic review Pediatr 130 717-77

[6] Holland A(2014)Lessons learned from our elders: how to study polypharmacy in populations with intellectual and developmental disabilities Intellect Dev Disabil 52 60-513

[7] Strydom A(2015)Adverse Events in Very Young Children Prescribed Psychotropic Medications: Preliminary Findings from an Acute Clinical Sample Journal of Child and Adolescent Psychopharmacology 25 509-436

[8] Tsiouris JA(2018)Puberty and the human brain: insights into adolescent development Neurosci Biobehav Rev 92 417-557

[9] Tyrer P(2018)Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research Ther Adv Drug Saf 9 535-103

[10] Hassiotis A(2016)Prevalence and putative risk markers of challenging behavior in students with intellectual disabilities Res Dev Disabil 58 94-489